カテゴリー： Market Monitor Global, 世界, 医療/バイオ

エポエチン（エリトロポエチン）の世界市場見通し2023年-2029年

◆英語タイトル：Epoetin (Eritropoyetin) Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5545）

◆商品コード：MMG23JU5545
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：78
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Epoetin (Eritropoyetin) Market 調査レポートは次の情報を含め、グローバルにおけるのエポエチン（エリトロポエチン）市場規模と予測を収録しています。・世界のエポエチン（エリトロポエチン）市場：売上、2018年-2023年、2024年-2029年
・世界のエポエチン（エリトロポエチン）市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のエポエチン（エリトロポエチン）市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「エポエチンアルファ」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

エポエチン（エリトロポエチン）のグローバル主要企業は、Amgen、 Epoetin、 Abcam、 Johnson & Johnson、 Hospira Inc、 Roche、 LG Life Sciences Ltd、 Biocon、 Intas Pharmaceuticals、 Teva Pharmaceutical Industries Ltd、 Ranbaxy Laboratories Ltd、 Celltrion, Incなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、エポエチン（エリトロポエチン）のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のエポエチン（エリトロポエチン）市場：タイプ別、2018年-2023年、2024年-2029年
世界のエポエチン（エリトロポエチン）市場：タイプ別市場シェア、2022年
・エポエチンアルファ、エポエチンベータ、ダルベポエチンアルファ

世界のエポエチン（エリトロポエチン）市場：用途別、2018年-2023年、2024年-2029年
世界のエポエチン（エリトロポエチン）市場：用途別市場シェア、2022年
・貧血（がん＆HIV治療）、腎臓障害（ESRD＆透析）、その他（神経疾患＆創傷治癒）

世界のエポエチン（エリトロポエチン）市場：地域・国別、2018年-2023年、2024年-2029年
世界のエポエチン（エリトロポエチン）市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるエポエチン（エリトロポエチン）のグローバル売上、2018年-2023年
・主要企業におけるエポエチン（エリトロポエチン）のグローバル売上シェア、2022年
・主要企業におけるエポエチン（エリトロポエチン）のグローバル販売量、2018年-2023年
・主要企業におけるエポエチン（エリトロポエチン）のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Amgen、 Epoetin、 Abcam、 Johnson & Johnson、 Hospira Inc、 Roche、 LG Life Sciences Ltd、 Biocon、 Intas Pharmaceuticals、 Teva Pharmaceutical Industries Ltd、 Ranbaxy Laboratories Ltd、 Celltrion, Inc

*************************************************************

・調査・分析レポートの概要
エポエチン（エリトロポエチン）市場の定義
市場セグメント
世界のエポエチン（エリトロポエチン）市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のエポエチン（エリトロポエチン）市場規模
世界のエポエチン（エリトロポエチン）市場規模：2022年 VS 2029年
世界のエポエチン（エリトロポエチン）市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのエポエチン（エリトロポエチン）の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のエポエチン（エリトロポエチン）製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：エポエチンアルファ、エポエチンベータ、ダルベポエチンアルファ
エポエチン（エリトロポエチン）のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：貧血（がん＆HIV治療）、腎臓障害（ESRD＆透析）、その他（神経疾患＆創傷治癒）
エポエチン（エリトロポエチン）の用途別グローバル売上・予測

・地域別市場分析
地域別エポエチン（エリトロポエチン）市場規模 2022年と2029年
地域別エポエチン（エリトロポエチン）売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Amgen、 Epoetin、 Abcam、 Johnson & Johnson、 Hospira Inc、 Roche、 LG Life Sciences Ltd、 Biocon、 Intas Pharmaceuticals、 Teva Pharmaceutical Industries Ltd、 Ranbaxy Laboratories Ltd、 Celltrion, Inc
...

Epoetin can be given intravenously or, more conveniently, subcutaneously, when a 25–50% lower dose can be used.
This report aims to provide a comprehensive presentation of the global market for Epoetin (Eritropoyetin), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Epoetin (Eritropoyetin). This report contains market size and forecasts of Epoetin (Eritropoyetin) in global, including the following market information:
Global Epoetin (Eritropoyetin) Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Epoetin (Eritropoyetin) Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Epoetin (Eritropoyetin) companies in 2022 (%)
The global Epoetin (Eritropoyetin) market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Epoetin-alfa Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Epoetin (Eritropoyetin) include Amgen, Epoetin, Abcam, Johnson & Johnson, Hospira Inc, Roche, LG Life Sciences Ltd, Biocon and Intas Pharmaceuticals, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Epoetin (Eritropoyetin) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Epoetin (Eritropoyetin) Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Epoetin (Eritropoyetin) Market Segment Percentages, by Type, 2022 (%)
Epoetin-alfa
Epoetin-beta
Darbepoetin Alfa
Global Epoetin (Eritropoyetin) Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Epoetin (Eritropoyetin) Market Segment Percentages, by Application, 2022 (%)
Anemia (Cancer and HIV Treatment)
Kidney Disorders (ESRD and Dialysis)
Others (Neural Disease and Wound Healing)
Global Epoetin (Eritropoyetin) Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Epoetin (Eritropoyetin) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Epoetin (Eritropoyetin) revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Epoetin (Eritropoyetin) revenues share in global market, 2022 (%)
Key companies Epoetin (Eritropoyetin) sales in global market, 2018-2023 (Estimated), (Units)
Key companies Epoetin (Eritropoyetin) sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen
Epoetin
Abcam
Johnson & Johnson
Hospira Inc
Roche
LG Life Sciences Ltd
Biocon
Intas Pharmaceuticals
Teva Pharmaceutical Industries Ltd
Ranbaxy Laboratories Ltd
Celltrion, Inc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Epoetin (Eritropoyetin), market overview.
Chapter 2: Global Epoetin (Eritropoyetin) market size in revenue and volume.
Chapter 3: Detailed analysis of Epoetin (Eritropoyetin) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Epoetin (Eritropoyetin) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Epoetin (Eritropoyetin) capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Epoetin (Eritropoyetin) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Epoetin (Eritropoyetin) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Epoetin (Eritropoyetin) Overall Market Size
2.1 Global Epoetin (Eritropoyetin) Market Size: 2022 VS 2029
2.2 Global Epoetin (Eritropoyetin) Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Epoetin (Eritropoyetin) Sales: 2018-2029
3 Company Landscape
3.1 Top Epoetin (Eritropoyetin) Players in Global Market
3.2 Top Global Epoetin (Eritropoyetin) Companies Ranked by Revenue
3.3 Global Epoetin (Eritropoyetin) Revenue by Companies
3.4 Global Epoetin (Eritropoyetin) Sales by Companies
3.5 Global Epoetin (Eritropoyetin) Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Epoetin (Eritropoyetin) Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Epoetin (Eritropoyetin) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Epoetin (Eritropoyetin) Players in Global Market
3.8.1 List of Global Tier 1 Epoetin (Eritropoyetin) Companies
3.8.2 List of Global Tier 2 and Tier 3 Epoetin (Eritropoyetin) Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Epoetin (Eritropoyetin) Market Size Markets, 2022 & 2029
4.1.2 Epoetin-alfa
4.1.3 Epoetin-beta
4.1.4 Darbepoetin Alfa
4.2 By Type – Global Epoetin (Eritropoyetin) Revenue & Forecasts
4.2.1 By Type – Global Epoetin (Eritropoyetin) Revenue, 2018-2023
4.2.2 By Type – Global Epoetin (Eritropoyetin) Revenue, 2024-2029
4.2.3 By Type – Global Epoetin (Eritropoyetin) Revenue Market Share, 2018-2029
4.3 By Type – Global Epoetin (Eritropoyetin) Sales & Forecasts
4.3.1 By Type – Global Epoetin (Eritropoyetin) Sales, 2018-2023
4.3.2 By Type – Global Epoetin (Eritropoyetin) Sales, 2024-2029
4.3.3 By Type – Global Epoetin (Eritropoyetin) Sales Market Share, 2018-2029
4.4 By Type – Global Epoetin (Eritropoyetin) Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Epoetin (Eritropoyetin) Market Size, 2022 & 2029
5.1.2 Anemia (Cancer and HIV Treatment)
5.1.3 Kidney Disorders (ESRD and Dialysis)
5.1.4 Others (Neural Disease and Wound Healing)
5.2 By Application – Global Epoetin (Eritropoyetin) Revenue & Forecasts
5.2.1 By Application – Global Epoetin (Eritropoyetin) Revenue, 2018-2023
5.2.2 By Application – Global Epoetin (Eritropoyetin) Revenue, 2024-2029
5.2.3 By Application – Global Epoetin (Eritropoyetin) Revenue Market Share, 2018-2029
5.3 By Application – Global Epoetin (Eritropoyetin) Sales & Forecasts
5.3.1 By Application – Global Epoetin (Eritropoyetin) Sales, 2018-2023
5.3.2 By Application – Global Epoetin (Eritropoyetin) Sales, 2024-2029
5.3.3 By Application – Global Epoetin (Eritropoyetin) Sales Market Share, 2018-2029
5.4 By Application – Global Epoetin (Eritropoyetin) Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Epoetin (Eritropoyetin) Market Size, 2022 & 2029
6.2 By Region – Global Epoetin (Eritropoyetin) Revenue & Forecasts
6.2.1 By Region – Global Epoetin (Eritropoyetin) Revenue, 2018-2023
6.2.2 By Region – Global Epoetin (Eritropoyetin) Revenue, 2024-2029
6.2.3 By Region – Global Epoetin (Eritropoyetin) Revenue Market Share, 2018-2029
6.3 By Region – Global Epoetin (Eritropoyetin) Sales & Forecasts
6.3.1 By Region – Global Epoetin (Eritropoyetin) Sales, 2018-2023
6.3.2 By Region – Global Epoetin (Eritropoyetin) Sales, 2024-2029
6.3.3 By Region – Global Epoetin (Eritropoyetin) Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Epoetin (Eritropoyetin) Revenue, 2018-2029
6.4.2 By Country – North America Epoetin (Eritropoyetin) Sales, 2018-2029
6.4.3 US Epoetin (Eritropoyetin) Market Size, 2018-2029
6.4.4 Canada Epoetin (Eritropoyetin) Market Size, 2018-2029
6.4.5 Mexico Epoetin (Eritropoyetin) Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Epoetin (Eritropoyetin) Revenue, 2018-2029
6.5.2 By Country – Europe Epoetin (Eritropoyetin) Sales, 2018-2029
6.5.3 Germany Epoetin (Eritropoyetin) Market Size, 2018-2029
6.5.4 France Epoetin (Eritropoyetin) Market Size, 2018-2029
6.5.5 U.K. Epoetin (Eritropoyetin) Market Size, 2018-2029
6.5.6 Italy Epoetin (Eritropoyetin) Market Size, 2018-2029
6.5.7 Russia Epoetin (Eritropoyetin) Market Size, 2018-2029
6.5.8 Nordic Countries Epoetin (Eritropoyetin) Market Size, 2018-2029
6.5.9 Benelux Epoetin (Eritropoyetin) Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Epoetin (Eritropoyetin) Revenue, 2018-2029
6.6.2 By Region – Asia Epoetin (Eritropoyetin) Sales, 2018-2029
6.6.3 China Epoetin (Eritropoyetin) Market Size, 2018-2029
6.6.4 Japan Epoetin (Eritropoyetin) Market Size, 2018-2029
6.6.5 South Korea Epoetin (Eritropoyetin) Market Size, 2018-2029
6.6.6 Southeast Asia Epoetin (Eritropoyetin) Market Size, 2018-2029
6.6.7 India Epoetin (Eritropoyetin) Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Epoetin (Eritropoyetin) Revenue, 2018-2029
6.7.2 By Country – South America Epoetin (Eritropoyetin) Sales, 2018-2029
6.7.3 Brazil Epoetin (Eritropoyetin) Market Size, 2018-2029
6.7.4 Argentina Epoetin (Eritropoyetin) Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Epoetin (Eritropoyetin) Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Epoetin (Eritropoyetin) Sales, 2018-2029
6.8.3 Turkey Epoetin (Eritropoyetin) Market Size, 2018-2029
6.8.4 Israel Epoetin (Eritropoyetin) Market Size, 2018-2029
6.8.5 Saudi Arabia Epoetin (Eritropoyetin) Market Size, 2018-2029
6.8.6 UAE Epoetin (Eritropoyetin) Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Amgen
7.1.1 Amgen Company Summary
7.1.2 Amgen Business Overview
7.1.3 Amgen Epoetin (Eritropoyetin) Major Product Offerings
7.1.4 Amgen Epoetin (Eritropoyetin) Sales and Revenue in Global (2018-2023)
7.1.5 Amgen Key News & Latest Developments
7.2 Epoetin
7.2.1 Epoetin Company Summary
7.2.2 Epoetin Business Overview
7.2.3 Epoetin Epoetin (Eritropoyetin) Major Product Offerings
7.2.4 Epoetin Epoetin (Eritropoyetin) Sales and Revenue in Global (2018-2023)
7.2.5 Epoetin Key News & Latest Developments
7.3 Abcam
7.3.1 Abcam Company Summary
7.3.2 Abcam Business Overview
7.3.3 Abcam Epoetin (Eritropoyetin) Major Product Offerings
7.3.4 Abcam Epoetin (Eritropoyetin) Sales and Revenue in Global (2018-2023)
7.3.5 Abcam Key News & Latest Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Company Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Epoetin (Eritropoyetin) Major Product Offerings
7.4.4 Johnson & Johnson Epoetin (Eritropoyetin) Sales and Revenue in Global (2018-2023)
7.4.5 Johnson & Johnson Key News & Latest Developments
7.5 Hospira Inc
7.5.1 Hospira Inc Company Summary
7.5.2 Hospira Inc Business Overview
7.5.3 Hospira Inc Epoetin (Eritropoyetin) Major Product Offerings
7.5.4 Hospira Inc Epoetin (Eritropoyetin) Sales and Revenue in Global (2018-2023)
7.5.5 Hospira Inc Key News & Latest Developments
7.6 Roche
7.6.1 Roche Company Summary
7.6.2 Roche Business Overview
7.6.3 Roche Epoetin (Eritropoyetin) Major Product Offerings
7.6.4 Roche Epoetin (Eritropoyetin) Sales and Revenue in Global (2018-2023)
7.6.5 Roche Key News & Latest Developments
7.7 LG Life Sciences Ltd
7.7.1 LG Life Sciences Ltd Company Summary
7.7.2 LG Life Sciences Ltd Business Overview
7.7.3 LG Life Sciences Ltd Epoetin (Eritropoyetin) Major Product Offerings
7.7.4 LG Life Sciences Ltd Epoetin (Eritropoyetin) Sales and Revenue in Global (2018-2023)
7.7.5 LG Life Sciences Ltd Key News & Latest Developments
7.8 Biocon
7.8.1 Biocon Company Summary
7.8.2 Biocon Business Overview
7.8.3 Biocon Epoetin (Eritropoyetin) Major Product Offerings
7.8.4 Biocon Epoetin (Eritropoyetin) Sales and Revenue in Global (2018-2023)
7.8.5 Biocon Key News & Latest Developments
7.9 Intas Pharmaceuticals
7.9.1 Intas Pharmaceuticals Company Summary
7.9.2 Intas Pharmaceuticals Business Overview
7.9.3 Intas Pharmaceuticals Epoetin (Eritropoyetin) Major Product Offerings
7.9.4 Intas Pharmaceuticals Epoetin (Eritropoyetin) Sales and Revenue in Global (2018-2023)
7.9.5 Intas Pharmaceuticals Key News & Latest Developments
7.10 Teva Pharmaceutical Industries Ltd
7.10.1 Teva Pharmaceutical Industries Ltd Company Summary
7.10.2 Teva Pharmaceutical Industries Ltd Business Overview
7.10.3 Teva Pharmaceutical Industries Ltd Epoetin (Eritropoyetin) Major Product Offerings
7.10.4 Teva Pharmaceutical Industries Ltd Epoetin (Eritropoyetin) Sales and Revenue in Global (2018-2023)
7.10.5 Teva Pharmaceutical Industries Ltd Key News & Latest Developments
7.11 Ranbaxy Laboratories Ltd
7.11.1 Ranbaxy Laboratories Ltd Company Summary
7.11.2 Ranbaxy Laboratories Ltd Epoetin (Eritropoyetin) Business Overview
7.11.3 Ranbaxy Laboratories Ltd Epoetin (Eritropoyetin) Major Product Offerings
7.11.4 Ranbaxy Laboratories Ltd Epoetin (Eritropoyetin) Sales and Revenue in Global (2018-2023)
7.11.5 Ranbaxy Laboratories Ltd Key News & Latest Developments
7.12 Celltrion, Inc
7.12.1 Celltrion, Inc Company Summary
7.12.2 Celltrion, Inc Epoetin (Eritropoyetin) Business Overview
7.12.3 Celltrion, Inc Epoetin (Eritropoyetin) Major Product Offerings
7.12.4 Celltrion, Inc Epoetin (Eritropoyetin) Sales and Revenue in Global (2018-2023)
7.12.5 Celltrion, Inc Key News & Latest Developments
8 Global Epoetin (Eritropoyetin) Production Capacity, Analysis
8.1 Global Epoetin (Eritropoyetin) Production Capacity, 2018-2029
8.2 Epoetin (Eritropoyetin) Production Capacity of Key Manufacturers in Global Market
8.3 Global Epoetin (Eritropoyetin) Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Epoetin (Eritropoyetin) Supply Chain Analysis
10.1 Epoetin (Eritropoyetin) Industry Value Chain
10.2 Epoetin (Eritropoyetin) Upstream Market
10.3 Epoetin (Eritropoyetin) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Epoetin (Eritropoyetin) Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Epoetin (Eritropoyetin) in Global Market
Table 2. Top Epoetin (Eritropoyetin) Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Epoetin (Eritropoyetin) Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Epoetin (Eritropoyetin) Revenue Share by Companies, 2018-2023
Table 5. Global Epoetin (Eritropoyetin) Sales by Companies, (Units), 2018-2023
Table 6. Global Epoetin (Eritropoyetin) Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Epoetin (Eritropoyetin) Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Epoetin (Eritropoyetin) Product Type
Table 9. List of Global Tier 1 Epoetin (Eritropoyetin) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Epoetin (Eritropoyetin) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Epoetin (Eritropoyetin) Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Epoetin (Eritropoyetin) Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Epoetin (Eritropoyetin) Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Epoetin (Eritropoyetin) Sales (Units), 2018-2023
Table 15. By Type - Global Epoetin (Eritropoyetin) Sales (Units), 2024-2029
Table 16. By Application – Global Epoetin (Eritropoyetin) Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Epoetin (Eritropoyetin) Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Epoetin (Eritropoyetin) Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Epoetin (Eritropoyetin) Sales (Units), 2018-2023
Table 20. By Application - Global Epoetin (Eritropoyetin) Sales (Units), 2024-2029
Table 21. By Region – Global Epoetin (Eritropoyetin) Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Epoetin (Eritropoyetin) Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Epoetin (Eritropoyetin) Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Epoetin (Eritropoyetin) Sales (Units), 2018-2023
Table 25. By Region - Global Epoetin (Eritropoyetin) Sales (Units), 2024-2029
Table 26. By Country - North America Epoetin (Eritropoyetin) Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Epoetin (Eritropoyetin) Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Epoetin (Eritropoyetin) Sales, (Units), 2018-2023
Table 29. By Country - North America Epoetin (Eritropoyetin) Sales, (Units), 2024-2029
Table 30. By Country - Europe Epoetin (Eritropoyetin) Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Epoetin (Eritropoyetin) Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Epoetin (Eritropoyetin) Sales, (Units), 2018-2023
Table 33. By Country - Europe Epoetin (Eritropoyetin) Sales, (Units), 2024-2029
Table 34. By Region - Asia Epoetin (Eritropoyetin) Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Epoetin (Eritropoyetin) Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Epoetin (Eritropoyetin) Sales, (Units), 2018-2023
Table 37. By Region - Asia Epoetin (Eritropoyetin) Sales, (Units), 2024-2029
Table 38. By Country - South America Epoetin (Eritropoyetin) Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Epoetin (Eritropoyetin) Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Epoetin (Eritropoyetin) Sales, (Units), 2018-2023
Table 41. By Country - South America Epoetin (Eritropoyetin) Sales, (Units), 2024-2029
Table 42. By Country - Middle East & Africa Epoetin (Eritropoyetin) Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Epoetin (Eritropoyetin) Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Epoetin (Eritropoyetin) Sales, (Units), 2018-2023
Table 45. By Country - Middle East & Africa Epoetin (Eritropoyetin) Sales, (Units), 2024-2029
Table 46. Amgen Company Summary
Table 47. Amgen Epoetin (Eritropoyetin) Product Offerings
Table 48. Amgen Epoetin (Eritropoyetin) Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Amgen Key News & Latest Developments
Table 50. Epoetin Company Summary
Table 51. Epoetin Epoetin (Eritropoyetin) Product Offerings
Table 52. Epoetin Epoetin (Eritropoyetin) Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Epoetin Key News & Latest Developments
Table 54. Abcam Company Summary
Table 55. Abcam Epoetin (Eritropoyetin) Product Offerings
Table 56. Abcam Epoetin (Eritropoyetin) Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Abcam Key News & Latest Developments
Table 58. Johnson & Johnson Company Summary
Table 59. Johnson & Johnson Epoetin (Eritropoyetin) Product Offerings
Table 60. Johnson & Johnson Epoetin (Eritropoyetin) Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Johnson & Johnson Key News & Latest Developments
Table 62. Hospira Inc Company Summary
Table 63. Hospira Inc Epoetin (Eritropoyetin) Product Offerings
Table 64. Hospira Inc Epoetin (Eritropoyetin) Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Hospira Inc Key News & Latest Developments
Table 66. Roche Company Summary
Table 67. Roche Epoetin (Eritropoyetin) Product Offerings
Table 68. Roche Epoetin (Eritropoyetin) Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Roche Key News & Latest Developments
Table 70. LG Life Sciences Ltd Company Summary
Table 71. LG Life Sciences Ltd Epoetin (Eritropoyetin) Product Offerings
Table 72. LG Life Sciences Ltd Epoetin (Eritropoyetin) Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. LG Life Sciences Ltd Key News & Latest Developments
Table 74. Biocon Company Summary
Table 75. Biocon Epoetin (Eritropoyetin) Product Offerings
Table 76. Biocon Epoetin (Eritropoyetin) Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Biocon Key News & Latest Developments
Table 78. Intas Pharmaceuticals Company Summary
Table 79. Intas Pharmaceuticals Epoetin (Eritropoyetin) Product Offerings
Table 80. Intas Pharmaceuticals Epoetin (Eritropoyetin) Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Intas Pharmaceuticals Key News & Latest Developments
Table 82. Teva Pharmaceutical Industries Ltd Company Summary
Table 83. Teva Pharmaceutical Industries Ltd Epoetin (Eritropoyetin) Product Offerings
Table 84. Teva Pharmaceutical Industries Ltd Epoetin (Eritropoyetin) Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Teva Pharmaceutical Industries Ltd Key News & Latest Developments
Table 86. Ranbaxy Laboratories Ltd Company Summary
Table 87. Ranbaxy Laboratories Ltd Epoetin (Eritropoyetin) Product Offerings
Table 88. Ranbaxy Laboratories Ltd Epoetin (Eritropoyetin) Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. Ranbaxy Laboratories Ltd Key News & Latest Developments
Table 90. Celltrion, Inc Company Summary
Table 91. Celltrion, Inc Epoetin (Eritropoyetin) Product Offerings
Table 92. Celltrion, Inc Epoetin (Eritropoyetin) Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 93. Celltrion, Inc Key News & Latest Developments
Table 94. Epoetin (Eritropoyetin) Production Capacity (Units) of Key Manufacturers in Global Market, 2021-2023 (Units)
Table 95. Global Epoetin (Eritropoyetin) Capacity Market Share of Key Manufacturers, 2021-2023
Table 96. Global Epoetin (Eritropoyetin) Production by Region, 2018-2023 (Units)
Table 97. Global Epoetin (Eritropoyetin) Production by Region, 2024-2029 (Units)
Table 98. Epoetin (Eritropoyetin) Market Opportunities & Trends in Global Market
Table 99. Epoetin (Eritropoyetin) Market Drivers in Global Market
Table 100. Epoetin (Eritropoyetin) Market Restraints in Global Market
Table 101. Epoetin (Eritropoyetin) Raw Materials
Table 102. Epoetin (Eritropoyetin) Raw Materials Suppliers in Global Market
Table 103. Typical Epoetin (Eritropoyetin) Downstream
Table 104. Epoetin (Eritropoyetin) Downstream Clients in Global Market
Table 105. Epoetin (Eritropoyetin) Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Epoetin (Eritropoyetin) Segment by Type in 2022
Figure 2. Epoetin (Eritropoyetin) Segment by Application in 2022
Figure 3. Global Epoetin (Eritropoyetin) Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Epoetin (Eritropoyetin) Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Epoetin (Eritropoyetin) Revenue, 2018-2029 (US$, Mn)
Figure 7. Epoetin (Eritropoyetin) Sales in Global Market: 2018-2029 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Epoetin (Eritropoyetin) Revenue in 2022
Figure 9. By Type - Global Epoetin (Eritropoyetin) Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Epoetin (Eritropoyetin) Revenue Market Share, 2018-2029
Figure 11. By Type - Global Epoetin (Eritropoyetin) Sales Market Share, 2018-2029
Figure 12. By Type - Global Epoetin (Eritropoyetin) Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Epoetin (Eritropoyetin) Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Epoetin (Eritropoyetin) Revenue Market Share, 2018-2029
Figure 15. By Application - Global Epoetin (Eritropoyetin) Sales Market Share, 2018-2029
Figure 16. By Application - Global Epoetin (Eritropoyetin) Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Epoetin (Eritropoyetin) Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Epoetin (Eritropoyetin) Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Epoetin (Eritropoyetin) Revenue Market Share, 2018-2029
Figure 20. By Region - Global Epoetin (Eritropoyetin) Sales Market Share, 2018-2029
Figure 21. By Country - North America Epoetin (Eritropoyetin) Revenue Market Share, 2018-2029
Figure 22. By Country - North America Epoetin (Eritropoyetin) Sales Market Share, 2018-2029
Figure 23. US Epoetin (Eritropoyetin) Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Epoetin (Eritropoyetin) Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Epoetin (Eritropoyetin) Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Epoetin (Eritropoyetin) Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Epoetin (Eritropoyetin) Sales Market Share, 2018-2029
Figure 28. Germany Epoetin (Eritropoyetin) Revenue, (US$, Mn), 2018-2029
Figure 29. France Epoetin (Eritropoyetin) Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Epoetin (Eritropoyetin) Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Epoetin (Eritropoyetin) Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Epoetin (Eritropoyetin) Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Epoetin (Eritropoyetin) Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Epoetin (Eritropoyetin) Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Epoetin (Eritropoyetin) Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Epoetin (Eritropoyetin) Sales Market Share, 2018-2029
Figure 37. China Epoetin (Eritropoyetin) Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Epoetin (Eritropoyetin) Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Epoetin (Eritropoyetin) Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Epoetin (Eritropoyetin) Revenue, (US$, Mn), 2018-2029
Figure 41. India Epoetin (Eritropoyetin) Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Epoetin (Eritropoyetin) Revenue Market Share, 2018-2029
Figure 43. By Country - South America Epoetin (Eritropoyetin) Sales Market Share, 2018-2029
Figure 44. Brazil Epoetin (Eritropoyetin) Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Epoetin (Eritropoyetin) Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Epoetin (Eritropoyetin) Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Epoetin (Eritropoyetin) Sales Market Share, 2018-2029
Figure 48. Turkey Epoetin (Eritropoyetin) Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Epoetin (Eritropoyetin) Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Epoetin (Eritropoyetin) Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Epoetin (Eritropoyetin) Revenue, (US$, Mn), 2018-2029
Figure 52. Global Epoetin (Eritropoyetin) Production Capacity (Units), 2018-2029
Figure 53. The Percentage of Production Epoetin (Eritropoyetin) by Region, 2022 VS 2029
Figure 54. Epoetin (Eritropoyetin) Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ エポエチン（エリトロポエチン）の世界市場見通し2023年-2029年(Epoetin (Eritropoyetin) Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

エポエチン（エリトロポエチン）の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp